focus -WSS

focus

author：leisure time 2025-10-02 00:43:19 - browse：9556

Illustration of a crowd of people looking toward a cityscape. — Adobe

Few public health challenges have been more daunting and persistent than the opioid crisis, which started because of egregious conduct by opioid manufacturers and now is driven by an influx of fentanyl. In my home state of New Hampshire — which has been at the forefront of this heartbreaking epidemic for more than a decade — too many promising futures have been snatched away. As we look to the next stage of bipartisan efforts to take on this challenge, we must quickly reauthorize and expand the SUPPORT Act, which expired Sept. 30. It laid a new foundation for our response to this epidemic — and now it can be used to increase access to the gold standard of treatment for addiction.

In 2018, we came together across party lines to pass the SUPPORT Act, which established vital infrastructure for communities in New Hampshire and across the country to treat addiction, help people recover, and prevent substance misuse in the first place.

While there are dozens of vital measures in this legislation, one of the most critical provisions helped expand access to medication-assisted treatment, the gold standard of addiction care. Access to this lifesaving medication, buprenorphine, has historically been limited by law and clinician reluctance, fueled by harmful stigmas surrounding addiction treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

WSS

The surgeon had a dilemma only a Nazi medical text could resolve

Prior authorization will have to move faster under new Biden rule

Insurer loopholes limit power of law against surprise medical bills

AI generated plenty of interest at JPM but not a lot of trust

Think you might have Covid

Florida Supreme Court upholds state's abortion ban

explore

focus

focus

23andMe had bad news about my health. I wish a person had delivered it

Insurer loopholes limit power of law against surprise medical bills

Medical leaders decry Supreme Court decision on affirmative action

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Duchenne breakthrough therapy leaves behind pioneering families

Harvard scientists, with Google, unveil the most detailed brain map ever

Jerome Adams on the need for new antivirals for Covid

The tragedy of Johnson & Johnson’s Covid vaccine

Peter Hotez and the public health issue of online harassment

Covid silver lining: Unprecedented look at human immune system

Wikipedia

Dewpoint Therapeutics lays off staff after losing partnerships

Bird flu in dairy cattle: New measures to control spread to humans

Insurer loopholes limit power of law against surprise medical bills

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Harvard scientists, with Google, unveil the most detailed brain map ever

EU regulator recommends expanding Mounjaro approval to obesity

explore

entertainment

knowledge

explore